Sinopharm offers to take Hong Kong-listed China-TCM private in nearly US$3 billion deal
A consortium led by state-owned pharmaceuticals giant Sinopharm has revived a take-private bid for China Traditional Chinese Medicine Holdings (China-TCM), the Hong-Kong-listed drug maker said on Wednesday, valuing it at …